Five Hours 2024 Prescriber Summit CME !
Video Link's sent upon registration.
Questions: Jenny White ([email protected])

Disclosure Statement:

Planning Committee Members: Claude Brunson, MD, J. Anthony Cloy, MD, Kristin Powell, LCSW, and Jenny White, planners of this educational activity, have no relevant financial relationships with ineligible companies to disclose.

Faculty: Faculty for this educational event have no relevant financial relationships with ineligible companies to disclose. 

LEARNING OBJECTIVES

Update on Rules & Regulations for Prescribing Controlled Substances: Ken Cleveland, MD

• Are you required to register as a Pain Management Clinic?
• Are you required to register as a Weight Loss Clinic?
• How often should a licensee check the PMP when prescribing controlled substances?
• Be able to calculate MME

Chronic Pain & Addiction: Dan Edney, MD

• Understand issues involving pain management.
• Identify and understand complications of chronic opioid use.
• Understand the concept of pain recovery and general treatment

Safety Conscious Prescribing for Higher Risk Patients: Deborah V. Gross, MD, FASAM, DABAM, LFAPA

• Identify safety sensitive and higher risk patients.
• Name seven essential executive brain functions.
• Prescribe safely for higher risk patients.
  

Evolution of Drug Culture: Colonel Steve Maxwell, BA, MA 

• Attendees will better understand the evolving nature and impact of today's drug culture.
• Attendees will understand the changing definitions of words and language used to describe persons and their actions associated with the America's drug culture.
• Attendees will understand the role science, technology, and marketing plays in the current drug culture.

Recognizing & Addressing Drug Seeking Behavior and Controlled Substance Diversion: A Pharmacists Perspective: Robert Jordan, PharmD

• Define Drug-Seeking Behavior: 

-Understand the concept of drug-seeking behavior and its implications for patient care. 
-Identify common indicators of drug-seeking behavior. 

• Recognize Controlled Substance Diversion: 

-Define controlled substance diversion and its impact on public health. 
-Recognize the pharmacist's role in preventing controlled substance diversion. 

• Understand Pharmacist's Prevention Strategies: 

-Comprehend the pharmacist's role in prescription review. 
-Understand the importance of utilizing Prescription Monitoring Programs (PMPs). 
-Recognize the significance of patient education in preventing diversion

The Mississippi State Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Mississippi State Medical Association designates this enduring material for a maximum of 5.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MSMA would like to thank the Mississippi Physicians Care Network

for its generous support of this event.